BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33711050)

  • 21. Inverse association between Helicobacter pylori and inflammatory bowel disease: myth or fact?
    Kayali S; Gaiani F; Manfredi M; Minelli R; Nervi G; Nouvenne A; Leandro G; Di Mario F; De' Angelis GL
    Acta Biomed; 2018 Dec; 89(9-S):81-86. PubMed ID: 30561399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-Helicobacter pylori gastritis is common among paediatric patients with inflammatory bowel disease.
    Genta RM; Sonnenberg A
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1310-6. PubMed ID: 22486730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Anti-Helicobacter pylori Therapy on Incidence of Autoimmune Diseases, Including Inflammatory Bowel Diseases.
    Lin KD; Chiu GF; Waljee AK; Owyang SY; El-Zaatari M; Bishu S; Grasberger H; Zhang M; Wu DC; Kao JY
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):1991-1999. PubMed ID: 30580094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel diseases].
    Pytrus T; Mowszet K; Krzesiek E; Rzeszutko M; Iwańczak B
    Pol Merkur Lekarski; 2008 Dec; 25(150):460-4. PubMed ID: 19205374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease - antibiotic use in the history does not play a significant role.
    Prónai L; Schandl L; Orosz Z; Magyar P; Tulassay Z
    Helicobacter; 2004 Jun; 9(3):278-83. PubMed ID: 15165265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China.
    Jiang L; Xia B; Li J; Ye M; Yan W; Deng C; Ding Y; Luo H; Hou W; Zhao Q; Liu N; Ren H; Hou X; Xu H
    Inflamm Bowel Dis; 2006 Mar; 12(3):212-7. PubMed ID: 16534423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010.
    Vcev A; Pezerovic D; Jovanovic Z; Nakic D; Vcev I; Majnarić L
    Wien Klin Wochenschr; 2015 May; 127(9-10):345-54. PubMed ID: 25821054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of sequential eradication therapy on serum osteoprotegerin levels in patients with
    Murad H; Rafeeq M; Mosli M; Gari M; Basheikh M
    J Int Med Res; 2021 Nov; 49(11):3000605211060648. PubMed ID: 34851775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
    Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
    World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role.
    Parente F; Cucino C; Bollani S; Imbesi V; Maconi G; Bonetto S; Vago L; Bianchi Porro G
    Am J Gastroenterol; 2000 Mar; 95(3):705-11. PubMed ID: 10710061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between Helicobacter pylori infection and Crohn's disease: a meta-analysis.
    Wang WL; Xu XJ
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10509-10516. PubMed ID: 31841206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori infection and inflammatory bowel disease in Asians: a meta-analysis.
    Wu XW; Ji HZ; Yang MF; Wu L; Wang FY
    World J Gastroenterol; 2015 Apr; 21(15):4750-6. PubMed ID: 25914487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low seroprevalence of Helicobacter pylori antibodies in historical sera of patients with Crohn's disease.
    Wagtmans MJ; Witte AM; Taylor DR; Biemond I; Veenendaal RA; Verspaget HW; Lamers CB; van Hogezand RA
    Scand J Gastroenterol; 1997 Jul; 32(7):712-8. PubMed ID: 9246713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease.
    Ungaro R; Chang HL; Côté-Daigneault J; Mehandru S; Atreja A; Colombel JF
    Am J Gastroenterol; 2016 Oct; 111(10):1416-1423. PubMed ID: 27296939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic review with meta-analysis: environmental and dietary differences of inflammatory bowel disease in Eastern and Western populations.
    Zhao M; Feng R; Ben-Horin S; Zhuang X; Tian Z; Li X; Ma R; Mao R; Qiu Y; Chen M
    Aliment Pharmacol Ther; 2022 Feb; 55(3):266-276. PubMed ID: 34820868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic risk factors for inflammatory bowel disease in a North-eastern Mexican population.
    Garza-González E; Pérez-Pérez GI; Mendoza-Ibarra SI; Flores-Gutiérrez JP; Bosques-Padilla FJ
    Int J Immunogenet; 2010 Oct; 37(5):355-9. PubMed ID: 20518842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of Crohn's Disease and Ulcerative Colitis in Rhode Island: Report from the Ocean State Crohn's and Colitis Area Registry.
    Shapiro JM; Zoega H; Shah SA; Bright RM; Mallette M; Moniz H; Grabert SA; Bancroft B; Merrick M; Flowers NT; Samad Z; Lidofsky S; LeLeiko NS; Sands BE
    Inflamm Bowel Dis; 2016 Jun; 22(6):1456-61. PubMed ID: 26926039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
    Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
    Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible protective effect of 5-aminosalicylic acid on Helicobacter pylori infection in patients with inflammatory bowel disease.
    Piodi LP; Bardella M; Rocchia C; Cesana BM; Baldassarri A; Quatrini M
    J Clin Gastroenterol; 2003 Jan; 36(1):22-5. PubMed ID: 12488702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.